Journal of Medical Internet Research
The leading peer-reviewed journal for digital medicine and health and health care in the internet age.
Editor-in-Chief:
Gunther Eysenbach, MD, MPH, FACMI, Founding Editor and Publisher; Adjunct Professor, School of Health Information Science, University of Victoria, Canada Rachele Hendricks-Sturrup, DHSc, MSc, MA, FACTS, Lead Editor; Research Director of Real-World Evidence, Duke-Margolis Institute for Health Policy, Washington, DC
Impact Factor 8.2 More information about Impact Factor CiteScore 10.4 More information about CiteScore
Recent Articles

High-risk alcohol use and alcohol use disorder (AUD) are significant contributors to surgical risk and complications yet remain underidentified in surgical populations. While electronic health records (EHRs) contain relevant information about patients’ alcohol use in clinical notes, manual chart review is time-intensive and impractical at scale. Natural language processing (NLP) offers a path to automated identification, but alcohol-related risk classes are highly imbalanced in clinical populations, making multiclass classification particularly challenging.

Remote consultations, including telephone, video, text, or web-based consultations, are now common in sexual and reproductive health services in England and Wales, offering convenience and efficiency but also raising concerns about the safeguarding of service users compared with in-person care. While guidance exists, evidence on how safeguarding is enacted remotely is limited.


Clinical AI is moving from systems that generate discrete predictions and recommendations toward agents capable of pursuing clinical objectives through repeated tool use, communication, planning, and state-changing actions. Emerging systems support multistep electronic health record workflows, and increasingly envision longitudinal care across repeated encounters. This transition expands safety assessment beyond discrete outputs and actions. Through its actions, an agent can help create the clinical state on which its subsequent decisions depend. Consequently, individually defensible actions may compose into an unsafe trajectory, even when no single action is clearly erroneous. We propose recoverability-centered trajectory governance as a clinical synthesis of established safety approaches, linking patient-specific corrective capacity to the continuing justification for delegated authority. Its central objective is clinical recoverability: preserving the opportunity for the human-AI care system to redirect care before clinically acceptable corrective pathways are exhausted. We define recovery margin as the remaining opportunity for such correction, and reauthorization boundaries as conditions requiring delegated authority to end or narrow pending renewed human judgment. This framing distinguishes reversibility, primarily a property of an action, from recoverability, a property of an evolving clinical trajectory. The operational framework combines persistent obligation tracking, independent monitoring, explicit reauthorization, authority contraction, graceful degradation, independent escalation, and verified human takeover. Oversight should concentrate at consequential trajectory junctions. Evaluation should combine trajectory stress testing, component-specific recovery-margin indicators, interruption-and-takeover testing, and population-level surveillance. Trajectory governance complements product lifecycle oversight by examining whether continued patient-specific delegation remains justified as care evolves. Because corrective capacity depends partly on access to timely monitoring and human rescue, recoverability is also an equity issue. The defining safety question is therefore not only whether an action is acceptable but whether continued delegation remains justified. The proposed indicators and governance mechanisms require domain-specific operationalization and empirical validation, including comparison with established safeguards.

Antithrombotic stewardship is critical for reducing preventable harm from inappropriate anticoagulant prescribing. Electronic health record (EHR)–embedded clinical decision support (CDS) alerts can prevent prescribing errors at the point of care, but their real-world effectiveness is variable and often limited by alert fatigue and poor workflow integration. Whether augmenting interruptive medication alerts with just‑in‑time access to clinical pharmacists improves prescriber response remains unclear.

This Viewpoint argues that measurement design, not model capability, is the first constraint on clinical AI in acute inpatient psychiatry and proposes intentional sufficiency as a design rule for sleep sensing on acute wards. Acute psychiatric wards exclude much of the conventional sensing design space: ligature, ingestion, and projectile hazards; unreliable adherence; impaired consent; and nursing workload mean that a device that is excellent when a patient is cooperative may be absent when the patient is most unwell. We define intentional sufficiency in 3 parts: the intended clinical use sets the required signal properties and acceptable error; safety, validity, consent, and workflow constraints define the feasible design space; and within that space, the rule selects the least burdensome option that preserves the required properties, because excess capability can be paid for in persistence, not only in money. We contrast this rule with capability-maximizing design using 2 examples at opposite ends of the design space: a structured nightly nursing sleep duration record that, in Taiwan, already exists within routine care, and a disposable wrist-worn sensing architecture under development that reduces the wearable to what the derived sleep measure requires. The first shows when the rule can conclude that no hardware should be added, provided adequacy has been shown for the intended use; the second shows when it concludes that hardware must be redesigned, and is presented as a design prediction rather than a result. Importantly, agreement with a reference method does not by itself establish task-level sufficiency; greater sensing capability does not necessarily produce more clinically available information when deployment and persistence are constrained; and some signal properties are validity defining and cannot be traded against cost.

Correct use of a pressurized metered-dose inhaler (pMDI), usually with a valved holding chamber, depends on use-related conditions that caregivers may not observe directly, including inhalation pattern, actuation-inhalation timing, mask seal, and device orientation. Many digital inhaler systems emphasize actuation or adherence. Systems that infer technique-related conditions from proxy signals may add real-time feedback but also create false reassurance if a positive state is displayed when evidence is inadequate. Caregiver expectations for such feedback and its failure states remain poorly characterized before prototype development.

Obesity prevention requires identifying nonobese adults at risk of developing obesity. Routine health checkups collect anthropometric, laboratory, medical history, and lifestyle information, but screening primarily describes current anthropometric status and does not directly provide individualized estimates of future risk for preventive counseling.

Glioblastoma (GBM) and brain metastasis (BM) are the most common malignant intracranial tumors in adults. Noninvasive differentiation between them remains challenging, as they frequently share similar imaging features. Although radiomics-based machine learning (ML) models show promise, systematic evidence of their performance remains limited.


Mobile health (mHealth) interventions for physical activity commonly combine several behavior change and digital design components, making it difficult to determine which components contribute to outcomes. Component estimates also depend on how repeated contrasts within trials and departures from additivity are handled.
Preprints Open for Peer Review
Open Peer Review Period:
-

















